Clinical Trials Browser

Phase NA × Interventional × Tinnitus × Clear all

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

NCT01549145 2012-08-29

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

Phase NA Completed

14 enrolled

Lymphoid

Lymphoma, Follicular, Tinnitus

Clinical Trials

TIMELY REHAB

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression